Fentanyl use while Breastfeeding
Drugs containing Fentanyl: Fentanyl Transdermal System, Duragesic, Subsys, Actiq, Sublimaze, Fentora, Abstral, Lazanda, Duragesic-25, Duragesic-12, Show all 16 »Innovar, Onsolis, Duragesic-100, Ionsys, Duragesic-75, Duragesic-50
Fentanyl Levels and Effects while Breastfeeding
Summary of Use during Lactation
When used epidurally or intravenously during labor or for a short time immediately postpartum, amounts of fentanyl ingested by the neonate are small and are not expected to cause any adverse effects in breastfed infants. No waiting period or discarding of milk is required before resuming breastfeeding after fentanyl is used for short procedures (e.g., for endoscopy). After general anesthesia, breastfeeding can be resumed as soon as the mother has recovered sufficiently from anesthesia to nurse. When a combination of anesthetic agents is used for a procedure, follow the recommendations for the most problematic medication used during the procedure. Limited information indicates that transdermal fentanyl in a dosage of 100 mcg/hour results in undetectable fentanyl concentrations in breastmilk.
<br Maternal use of oral narcotics during breastfeeding can cause infant drowsiness, central nervous system depression and even death. Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of fentanyl to a few days at a low dosage with close infant monitoring. If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately.
The results of studies on the effect of epidural fentanyl on breastfeeding initiation and duration are mixed and controversial, because of the many different combinations of drugs, dosages and patient populations studied as well as the variety of techniques used and deficient design of many of the studies. However, it appears that with good breastfeeding support, epidural fentanyl plus bupivacaine has little or no effect on breastfeeding success. Labor pain medication may delay the onset of lactation.
Plasma fentanyl levels of 0.2 to 1.2 mcg/L are required for analgesia via the nonepidural route and plasma levels over 1 to 2 mcg/L may cause respiratory depression. Plasma levels are markedly lower when the epidural route is used. The oral bioavailability of fentanyl is 33% in adults. The usual intravenous of fentanyl for an infant is 1 to 2 mcg/kg. Fentanyl is metabolized to norfentanyl and inactive metabolites.
Maternal Levels. Eight women who had undergone cesarean section received fentanyl 100 mcg epidurally immediately after delivery. Fentanyl was undetectable (<0.1 mcg/L) in colostrum at about 1 hour after the dose.
Thirteen women were given a single fentanyl 2 mcg/kg intravenous dose during either cesarean section or postpartum tubal ligation. Colostrum was collected at 0.75, 2, 4, 6, 8, and 10 hours after the dose. The average peak fentanyl level was 0.40 mcg/L and occurred 45 minutes after the dose. Average levels declined to 0.22 mcg/L at 2 hours and to 0.15 mcg/L at 4 hours then to the lower limit of the assay (0.05 mcg/L) at 6, 8, and 10 hours after the dose. Based on the peak milk fentanyl level reported in this study, an exclusively breastfed infant would receive a fentanyl dose of 0.06 mcg/kg daily.
Ten women were given 50 to 100 mcg of intravenous fentanyl every hour during labor. Their breastmilk was sampled 4 and 24 hours after delivery. The cumulative maternal fentanyl dosages ranged from 50 to 400 mcg and the longest time from last dose to delivery was 3.1 hours (range 0 to 3.1 hours). Fentanyl was undetectable (<0.05 mcg/L) in the milk of 8 of the women 4 hours after delivery and in 2 of the women 24 hours after delivery. Detectable milk levels of fentanyl ranged from 0.12 to 0.15 mcg/L at 4 hours after delivery and from 0.12 to 0.14 mcg/L at 24 hours after delivery. Based on the highest milk level reported in this study, an exclusively breastfed infant would receive a fentanyl dosage of 0.02 mcg/kg daily.
Five women who were 6 to 15 weeks postpartum were given a single dose of 100 mcg of fentanyl intravenously before undergoing general anesthesia. Several milk samples were collected between 5 and 24 hours after the injection from each woman. The authors estimated that the infants would receive an average of 0.005 mcg/kg in the 24 hours after a single dose of fentanyl. This corresponds to about 0.38 % of the maternal weight-adjusted dosage. The women's milk output following the surgical procedure was less than half of the normal milk output of nursing mothers. The authors concluded that this amount of fentanyl in milk is unlikely to affect a healthy, term infant. The infants of mothers not undergoing a surgical procedure might receive a greater dose of fentanyl in breastmilk, but it would be unlikely to be a large dose.
A randomized, prospective study measured colostrum fentanyl concentrations following epidural or intravenous fentanyl during delivery in 100 multiparous mothers undergoing cesarean section and delivering fullterm, healthy infants. Epidural fentanyl was given to 50 women in a dose of 100 to 150 mcg in divided doses followed by a continuous epidural infusion of 20 mcg/hour. Intravenous fentanyl was given to 50 women as a single dose of 50 mcg after delivery. Both groups received epidural or spinal bupivacaine in addition. Colostrum samples were obtained 45 minutes and 24 hours after the initial fentanyl dose. At 45 minutes, colostrum fentanyl concentrations were 0.4 mcg/L in the epidural group and 0.19 mcg/L in the intravenous group. At 24 hours, colostrum fentanyl concentrations were 80 ng/L in the epidural group and 0.05 mcg/L in the intravenous group. The authors estimated that in the worst-case scenario, a fully breastfed infant would absorb a fentanyl dose of 0.016 mcg/kg.
A woman was using a transdermal fentanyl patch for chronic back pain during pregnancy and postpartum. The mother required additional analgesia during labor and the infant required treatment for neonatal abstinence syndrome. By 2 weeks postpartum, the mother was using a fentanyl patch in a dosage of 100 mcg/hour which was changed every other day. A sample of pumped breastmilk from one breast contained fentanyl 6.4 mcg/L and norfentanyl 6.2 mcg/L.
Infant Levels. An infant whose mother was using a fentanyl patch in a dosage of 100 mcg/hour which was changed every other day was fed her mother's milk either by bottle or by the breast every 3 hours beginning about 2 weeks postpartum. On day 27 of life, the infant was fed 380 mL of maternal milk following several feedings during the prior 24 hours. The infant's serum fentanyl and norfentanyl concentrations were not detectable (<0.1 mcg/L).
Effects in Breastfed Infants
Fentanyl was possibly the cause of statistically significant, but clinically unimportant, lower neurobehavioral scores in a group of 32 newborns who were less than 24 hours old and whose mothers had received epidural fentanyl during labor.
An epidural fentanyl dosage greater than 150 mcg during labor was associated with slightly lower neurobehavioral scores in the newborns of 177 breastfeeding mothers on postpartum day 1 compared to a lower total dosage or to no fentanyl; however, this might have been a chance association and was probably due to placental transfer of fentanyl prior to delivery and not from breastmilk after delivery. All women also received epidural bupivacaine.
A woman was using a transdermal fentanyl patch for chronic back pain during pregnancy and postpartum. The mother required additional analgesia during labor and the infant required treatment for neonatal abstinence syndrome. By 2 weeks postpartum, the mother was using a fentanyl patch in a dosage of 100 mcg/hour which was changed every other day and the infant was being fed the mother's milk every 3 hours. The infant had no additional medical problems and fed well until discharge after day 27 of life, gaining 500 g.
Effects on Lactation and Breastmilk
Fentanyl can increase serum prolactin. However, the prolactin level in a mother with established lactation may not affect her ability to breastfeed.
In 58 breastfeeding mothers who received an epidural fentanyl dosage greater than 150 mcg during labor, 21% reported more difficulty in establishing breastfeeding at 24 hours after delivery compared to 10% of mothers who received to a lower dosage or to no fentanyl. There was no difference in breastfeeding difficulty noted between the groups 24 hours after delivery when the assessment was performed by a lactation consultant. Women in the high-dose group who could be contacted were more likely to discontinue breastfeeding by 6 weeks after delivery and there was a higher rate of breastfeeding discontinuation at 6 weeks among mothers who reported breastfeeding difficulty 24 hours after delivery. A relatively high dropout rate from the study at 6 weeks clouds the results.
A retrospective study of a random sample of 425 mothers delivering in a maternity unit found a dose-related increased risk of bottle feeding at hospital discharge associated with fentanyl administered during labor.
A prospective cohort study compared women who received continuous epidural analgesia with fentanyl and either bupivacaine or ropivacaine during labor and delivery (n = 52) to women who received no analgesia (n = 63). The average total fentanyl dosage was 124 mcg and the average total infusion time from start to delivery was 219 minutes. The study found no differences between the groups in breastfeeding effectiveness or infant neurobehavioral status at 8 to 12 hours postpartum or the number exclusively or partially breastfeeding at 4 weeks postpartum.
A randomized, prospective study measured infant breastfeeding behavior following epidural or intravenous fentanyl during delivery in 100 multiparous mothers undergoing cesarean section and delivering fullterm, healthy infants. Epidural fentanyl was given to 50 women in a dose of 100 to 150 mcg in divided doses followed by a continuous epidural infusion of 20 mcg/hour. Intravenous fentanyl was given to 50 women as a single dose of 50 mcg after delivery. Both groups received epidural or spinal bupivacaine in addition. A slight difference was seen in breastfeeding behavior between the groups, with the infants in the intravenous fentanyl group performing slightly worse than those in the epidural group. However, all mothers were able to breastfeed their infants at 24 hours. None had severe breastfeeding problems; 10 women in the epidural group reported mild or moderate problems and 7 women in the intravenous group reported breastfeeding problems. Twenty mothers in the epidural group and 14 in the intravenous group used supplemental bottle feeding, with the difference not statistically significant.
A randomized, multicenter trial compared the initiation rate and duration of breastfeeding in women who received high-dose epidural bupivacaine alone, or one of two low-dose combinations of bupivacaine plus fentanyl. The average fentanyl dosages in the two groups were 97 and 151 mcg in the first stage of labor and 10 and 12 mcg of fentanyl during the second stage of labor, respectively, with great variability. A nonepidural matched control group was also compared. No differences in breastfeeding initiation rates or duration were found among the epidural and nonmedicated groups, but women in the nonepidural group who received systemic meperidine had a lower breastfeeding initiation rate than in the other groups.
A nonrandomized study in low-risk mother-infant pairs found that there was no difference overall in the amount of sucking by newborns, whether their mothers received bupivacaine plus fentanyl, or fentanyl alone by epidural infusion in various dosages, or received no analgesia for childbirth. In a subanalysis by sex and number of sucks, female infants were affected by high-dose bupivacaine and high-dose fentanyl, but male infant were not. However, the imbalances of many factors between the study groups makes this study difficult to interpret.
In a prospective cohort study, 87 multiparous women who received epidural bupivacaine and fentanyl for pain control during labor and vaginal delivery. A loading dose of 0.125% bupivacaine with fentanyl 50-100 mcg. Epidural analgesia is maintained using 0.0625% bupivacaine and fentanyl 0.2 mcg/mL. The median dose of fentanyl received by the women was 151 mcg (range 30 to 570 mcg). The women completed questionnaires at 1 and 6 weeks postpartum regarding breastfeeding. Most women had prior experience with breastfeeding, support at home and ample time off from work. All women were breastfeeding at 1 week postpartum and 95.4% of women were breastfeeding at 6 weeks postpartum.
A nonrandomized study at one Italian hospital compared primaparous mothers undergoing vaginal delivery who received epidural analgesia (n = 64) to those who did not (n = 64). Mothers who requested the epidural analgesia received an initial dose of 100 mcg of fentanyl diluted to 10 mL with saline. After the initial fentanyl, doses of 15 to 20 mL of 0.1% ropivacaine were administered if needed. The only difference between the groups of mothers was a longer duration of labor among the treated mothers. The quality of infant nursing was equal between the 2 groups of infants on several measures; however, more infants in the treated group breastfed for less than 30 minutes at the first feeding.
A national survey of women and their infants from late pregnancy through 12 months postpartum compared the time of lactogenesis II in mothers who did and did not receive pain medication during labor. Categories of medication were spinal or epidural only, spinal or epidural plus another medication, and other pain medication only. Women who received medications from any of the categories had about twice the risk of having delayed lactogenesis II (>72 hours) compared to women who received no labor pain medication.
Alternate Drugs to Consider
1. Shergill AK, Ben-Menachem T, Chandrasekhara V et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc. 2012;76:18-24. PMID: 22579258
2. Vargo JJ, Delegge MH, Feld AD et al. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastroenterology. 2012;143:e18-41. PMID: 22624720
3. Reynolds F. Labour analgesia and the baby: good news is no news. Int J Obstet Anesth. 2011;20:38-50. PMID: 21146977
4. Loubert C, Hinova A, Fernando R. Update on modern neuraxial analgesia in labour: a review of the literature of the last 5 years. Anaesthesia. 2011;66:191-212. PMID: 21320088
5. Shrestha B, Devgan A, Sharma M. Effects of maternal epidural analgesia on the neonate - a prospective cohort study. Ital J Pediatr. 2014;40:99. PMID: 25492043
6. Zuppa A, Alighieri G, Riccardi R et al. Epidural analgesia, neonatal care and breastfeeding. Ital J Pediatr. 2014;40: 82. PMID: 25432659
7. Madej TH, Strunin L. Comparison of epidural fentanyl with sufentanil. Anaesthesia. 1987;42:1156-61. PMID: 2963561
8. Steer PL, Biddle CJ, Marley WS et al. Concentration of fentanyl in colostrum after an analgesic dose. Can J Anaesth. 1992;39:231-5. PMID: 1551153
9. Leuschen MP, Wolf LJ, Rayburn WF. Fentanyl excretion in breast milk. Clin Pharm. 1990;9:336-7. Letter. PMID: 2350936
10. Nitsun M, Szokol JW L et al. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther. 2006;79:549-57. PMID: 16765143
11. Goma HM, Said RN, El-Ela AM. Study of the newborn feeding behaviors and fentanyl concentration in colostrum after an analgesic dose of epidural and intravenous fentanyl in cesarean section. Saudi Med J. 2008;29:678-82. PMID: 18454213
12. Cohen RS. Fentanyl transdermal analgesia during pregnancy and lactation. J Hum Lact. 2009;25:359-61. PMID: 19286842
13. Ekwa-Ekoko C, Beilin Y, Abramowitz S, Holzman I , Weiser J, Kavanaugh N. Labor epidural fentanyl and new-born breast-feeding. Pediatr Res. 2000;47 (4 Pt 2):187A. Abstract.
14. Beilin Y, Bodian CA, Weiser J et al. Effect of labor epidural analgesia with and without fentanyl on infant breast-feeding: a prospective, randomized, double-blind study. Anesthesiology. 2005;103:1211-7. PMID: 16306734
15. Halpern SH, Ioscovich A. Epidural analgesia and breast-feeding. Anesthesiology. 2005;103:1111-2. Editorial. PMID: 16306720
16. Frecska E, Perenyi A, Arato M. Blunted prolactin response to fentanyl in depression. Normalizing effect of partial sleep deprivation. Psychiatry Res. 2003;118:155-64. PMID: 12798980
17. Naito Y, Tamai S, Fukata J et al. Comparison of endocrinological stress response associated with transvaginal ultrasound-guided oocyte pick-up under halothane anaesthesia and neuroleptanaesthesia. Can J Anaesth. 1989;36:633-6. PMID: 2555076
18. Jordan S, Emery S, Bradshaw C et al. The impact of intrapartum analgesia on infant feeding . BJOG. 2005;112:927-34. PMID: 15957994
19. Chang ZM, Heaman MI. Epidural analgesia during labor and delivery: effects on the initiation and continuation of effective breastfeeding. J Hum Lact. 2005;21:305-14. PMID: 16113019
20. Wilson MJ, Macarthur C, Cooper GM et al. Epidural analgesia and breastfeeding: a randomised controlled trial of epidural techniques with and without fentanyl and a non-epidural comparison group. Anaesthesia. 2009. PMID: 19912160
21. Bell AF, White-Traut R, Medoff-Cooper B. Neonatal neurobehavioral organization after exposure to maternal epidural analgesia in labor. J Obstet Gynecol Neonatal Nurs. 2010;39:178-90. PMID: 20409118
22. Wieczorek PM, Guest S, Balki M et al. Breastfeeding success rate after vaginal delivery can be high despite the use of epidural fentanyl: an observational cohort study. Int J Obstet Anesth. 2010;19:273-7. PMID: 20627690
23. Gizzo S, Di Gangi S, Saccardi C et al. Epidural analgesia during labor: impact on delivery outcome, neonatal well-being, and early breastfeeding. Breastfeed Med. 2012;7:262-8. PMID: 22166068
24. Lind JN, Perrine CG, Li R. Relationship between use of labor pain medications and delayed onset of lactation. J Hum Lact. 2014;30:167-73. PMID: 24451212
CAS Registry Number
LactMed Record Number
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.